Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma
Sign Up to like & getrecommendations! Published in 2019 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.24508
Abstract: There are no published reports for anti‐interleukin‐5 therapy in children read more here.
Keywords: children aged; severe eosinophilic; mepolizumab children; eosinophilic asthma ... See more keywords